Today: 2 March 2026
Browse Category

Stock Market 26 September 2025

Ghost of Yōtei Review Bombshell: Is PlayStation’s New Samurai Epic a Masterpiece—or Just More of the Same?

Ghost of Yōtei Review Bombshell: Is PlayStation’s New Samurai Epic a Masterpiece—or Just More of the Same?

Ghost of Yōtei, a PS5-exclusive sequel to Ghost of Tsushima, launches October 2, 2025, starring mercenary Atsu in 1603 Hokkaidō. Reviews average around 87–89 on Metacritic and OpenCritic, with praise for writing, performances, and combat but some criticism of pacing. The game costs $69.99, with a Digital Deluxe edition at $79.99, and will receive a free co-op expansion in 2026. Limited-edition hardware arrives the same day.
26 September 2025
Electronic Arts Stock Skyrockets on $50 Billion Buyout Rumors – Latest Price & Outlook (Sept 2025)

Electronic Arts Stock Skyrockets on $50 Billion Buyout Rumors – Latest Price & Outlook (Sept 2025)

Electronic Arts shares jumped nearly 15% to a record $193 on Friday after reports of a possible $50 billion buyout led by Silver Lake and Saudi Arabia’s Public Investment Fund. The rumored deal would be the largest leveraged buyout in history. EA’s market cap before the news was around $42–43 billion. The company recently beat earnings estimates and reported $1.1 billion in net income for fiscal 2025.
IREN Stock Today (Sept 26, 2025): AI Cloud Moonshot Meets Wall Street Reality Check—Is the Rally Just Pausing or Running Out of Fuel?

IREN Stock Today (Sept 26, 2025): AI Cloud Moonshot Meets Wall Street Reality Check—Is the Rally Just Pausing or Running Out of Fuel?

IREN shares fell 13.2% to $40.20 after JPMorgan downgraded the stock to Underweight and raised its target to $24. The move follows a week of volatility, including a $674 million GPU expansion and bullish analyst targets up to $82. Bitcoin traded near $109,107, down 2.1%. IREN reported FY2025 revenue of $501 million and its first annual profit.
26 September 2025
Wall Street Rebounds: PCE In‑Line, Tariff Shock, and Fed‑Cut Bets — What It All Means (Sept. 26, 2025)

Wall Street Rebounds: PCE In‑Line, Tariff Shock, and Fed‑Cut Bets — What It All Means (Sept. 26, 2025)

U.S. inflation matched forecasts in August, with PCE up 0.3% from July and 2.7% year-on-year. Stocks rebounded, the S&P 500 and Dow rising about 0.5% by early afternoon. The White House announced new tariffs on drug imports, trucks, and furniture, effective Oct. 1. Treasury yields slipped, with the 10-year near 4.18% after the data release.
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook

A One‑Time Brain Gene Therapy Just Slowed Huntington’s by 75%—Is This the Turning Point Families Have Waited For?

Early trial data show AMT-130 gene therapy slowed Huntington’s disease progression by 75% at 36 months in high-dose patients compared to controls. Treated participants’ neurofilament light levels dropped below baseline. The neurosurgical procedure lasts 12–20 hours. The developer plans a U.S. regulatory filing in 2026 if results hold.
26 September 2025
Boeing Stock Soars on Mega-Orders but Faces Turbulence – Key 2025 Update

Boeing Stock Soars on Mega-Orders but Faces Turbulence – Key 2025 Update

Boeing shares closed at $213.53 on Sept. 25, down 9% in 30 days but up over 40% year-on-year. Major September orders from Turkish Airlines, WestJet, and Norwegian Group pushed Boeing’s backlog to $619 billion. The FAA opened a probe into 737 MAX production delays, sending shares down 4% in one day. Boeing narrowed Q2 losses but still carries $53.3 billion in debt and has not restored its dividend.
26 September 2025
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer shares closed at $23.60 on Sept. 25, 2025, down 9% year-to-date and 18% from a year ago, near the bottom of their 52-week range. The dividend yield has risen above 7% as the stock slumped. In September, Pfizer announced a $7.3 billion acquisition of Metsera and reported strong Phase 3 results for a new COVID-19 vaccine. A key court hearing on Depo-Provera lawsuits is set for Sept. 29.
SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

SNAP Stock Just Got a 48‑Hour Jolt: India Creator Boom, New Sticker Push—and a $14B TikTok Twist Investors Can’t Ignore

Snap shares closed Sept 25 at $8.33, up 1.34% on heavy volume, bucking a broader tech decline. The company launched new sticker features for iMessage and Snapchat Keyboard that day. On Sept 26, Snap reported content viewership in India doubled in two years. A securities class action deadline looms Oct 20 amid ongoing legal scrutiny.
26 September 2025
RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

RIG Stock Meltdown: Transocean’s $381M Share Sale Rocks the Market—Will 13% Dilution Fix the Debt Problem or Set Up a Rebound?

Transocean priced an upsized public equity offering of 125 million shares at $3.05 each on Sept. 25, targeting $381.25 million in gross proceeds. Shares fell about 13–17% in premarket trading after the announcement, last trading at $3.16 on Sept. 26. Proceeds are earmarked mainly for debt repayment, including part of $655 million in 8% notes due 2027. The offering increases the share count by about 13%.
26 September 2025
PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

PLUG Stock’s 48-Hour Whirlwind: ‘Street‑High’ $4 Target, Oppenheimer’s “first recovery step,” and a hydrogen‑sector reality check (Sept. 25–26, 2025)

Plug Power shares closed at $2.36 on Sept. 25, down 1.67%, with trading volume surging to 113.8 million. Craig-Hallum set a new Street-high $4 price target on Sept. 26. An SEC filing registered 185.4 million warrant shares at $2, raising potential liquidity but adding supply risk. About 40% of PLUG’s float is sold short.
26 September 2025
DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

DVLT Just Landed a $150M Bitcoin Lifeline — Can Datavault AI Turn a Penny Stock Into an AI Supercomputer?

Datavault AI signed a $150 million Bitcoin-funded investment deal with Scilex Holding, split into two tranches. The first $8.067 million is set to close Sept. 26, with the remaining $141.933 million pending shareholder approval due to Nasdaq rules. Scilex will receive up to 278.9 million DVLT shares and board nomination rights. DVLT stock jumped over 28% on Sept. 25 and rose further in pre-market trading.
AMPY Just Popped ~22% in a Day — Is Amplify Energy’s Rally For Real or a Head‑Fake? What the Fresh Data (Sept. 25–26) Really Shows

AMPY Just Popped ~22% in a Day — Is Amplify Energy’s Rally For Real or a Head‑Fake? What the Fresh Data (Sept. 25–26) Really Shows

Amplify Energy shares surged 21.7% to $5.84 on Sept. 25, trading 13.5 million shares—more than 20 times the prior day’s volume. The spike followed insider buying in August and new analysis on Sept. 26 highlighting potential debt-reducing asset sales. Peers showed little movement, and oil prices slipped, suggesting the rally was company-specific.
SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

SPRC Rockets 59% After “Quantum Leap”: What Really Drove SciSparc’s Two‑Day Surge (Sept. 25–26) — And What Comes Next

SciSparc shares jumped 59% to $6.09 on Sept. 25 after announcing a quantum-computing 3D protein-modeling initiative and plans for a new Israeli subsidiary. Trading volume spiked nearly 555-fold. The company also disclosed leadership changes and faces a court-ordered pause on its pending merger with AutoMax until Sept. 30.
26 September 2025
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

Plus Therapeutics’ CNSide Diagnostics signed a national agreement with UnitedHealthcare to cover its CNSide tumor cell test, effective Sept. 15, potentially reaching over 51 million members. PSTV shares surged about 60% premarket on Sept. 25 after the news. CNSide’s Houston lab secured CLIA accreditation the prior week. Plus Therapeutics also received $1.9 million in non-dilutive funding from CPRIT on Sept. 22.
Forza Horizon 6 Speeds Into Japan – Release Window, New Features & Everything We Know

Forza Horizon 6 Goes Full Send: Japan Setting, 2026 Launch, ‘Biggest Map Yet,’ PS5 Post‑Launch—All the Breaking News From Sept 25–26, 2025

Forza Horizon 6 was revealed at Xbox’s Tokyo Game Show 2025 broadcast, confirming Japan as the setting and a 2026 release. The game launches first on Xbox Series X|S and PC, with PS5 to follow. Game Pass subscribers get day-one access. Early Instagram ads leaked the Japan location and release window hours before the official stream.
26 September 2025
Nintendo Shadow-Drops Fire Emblem Shadows – An Among Us-Style Fire Emblem Mobile RPG

Nintendo’s Surprise ‘Fire Emblem Shadows’ Drop: Why This Among Us‑Style Spin‑Off Could Rewire Nintendo’s Mobile Strategy

Nintendo released Fire Emblem Shadows, a free-to-start mobile spin-off, on September 25 for iOS and Android. The game mixes real-time tactics with social deduction, requiring players to identify a traitor among their team. Developed with Intelligent Systems and DeNA, it features a paid season pass and optional purchases. This is Nintendo’s first new mobile title in six years.
26 September 2025
AI Stocks on a Rollercoaster: Mega-Deals, Soaring Valuations & Bubble Jitters (Sept 25–26 Roundup)

AI Stocks on a Rollercoaster: Mega-Deals, Soaring Valuations & Bubble Jitters (Sept 25–26 Roundup)

Nvidia plans up to $100 billion in investments and chip supplies for OpenAI, fueling speculation of $500 billion in future sales. Oracle secured a $300 billion cloud contract with OpenAI and raised $18 billion in debt, but its stock fell 5% amid profit-taking. Major AI stocks, including Nvidia and Tesla, dropped as investors grew cautious. CoreWeave and Scale AI landed multi-billion dollar deals; Intel received $2 billion from SoftBank.
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

European stocks hit three-week lows Thursday, then rebounded Friday as the STOXX 600 fell 0.7% before rising 0.3%. U.S. President Trump’s new tariffs on drugs and trucks triggered a 2% drop in major pharma and truck stocks. The Bank of England warned on persistent UK inflation, while the ECB and Swiss National Bank held rates steady. Germany’s consumer confidence improved; Spain’s GDP beat forecasts.
Go toTop